When Drug Companies Do Their Own Research The Result Is… Predictable


I was intrigued by the research that stem cell therapy in dogs with hip displasia results in 96% of dogs ‘improving’, until I realized who was doing the research:

The figures were collected from vets by Australian Veterinary Stem Cells, which supplies stem cell treatments and has a partnership with the immunology and stem cell research department at Monash University in Melbourne.
The sample size for the study was small at 150 but only about 1000 animals have had the treatment.
The results found that with an injection into the affected joint, 60 per cent of dogs had a ”significant improvement” while 96 per cent of dogs showed ”improvement”.

What exactly does it mean, shown ‘improvement’? A lame dog given anti inflammatory medication will also reliably show ‘improvement’. And that’s for a lot cheaper then the $2,000 pricetag of a stem cell procedure. If I am going to invest that kind of money, I need to know that my dog will improve dramatically and that the improvement will last!

A study done on only 150 dogs and by a company why has a financial interest in the procedure is not going to persuade me. If I am going to offer it in my surgery, I need a little more of that pesky thing called ‘scientific evidence’.

About Dr Vadim Chelom

Dr Vadim is a house call Veterinarian in Melbourne
%d bloggers like this: